Market Tracker

10/20 5:16pm ET

Gilead Sciences Inc (NASDAQ:GILD)

81.21
Delayed Data
As of Oct 20
 -0.38 / -0.47%
Today’s Change
63.76
Today|||52-Week Range
86.27
+13.41%
Year-to-Date

Today’s Trading

Previous close81.59
Today’s open81.95
Day’s range80.45 - 81.95
Volume9,188,325
Average volume (3 months)9,520,406
Market cap$106.1B
Dividend yield2.56%
Data as of 4:14pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)-6.45%
Revenue growth (last year)-5.37%
P/E ratio8.8
Price/Sales3.21
Price/Book5.63

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.16-0.63%
BIIBBiogen-4.32-1.26%
ILMNIllumina Inc+4.70+2.29%
----
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$2.13
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts